Sequential serum cytokine levels of TNF-alpha, IL-4 and IL-12 are associated with prognosis in Plasmodium falciparum malaria

Indian Journal of Clinical Biochemistry

Volumn 29, Issue 3, 2014, Pages 321-326

  Mohapatra, P C ^a   Sarangi, Anshuman ^a   Sarangi, Ashok Kumar ^b   Dalai, R K ^a   Sahoo, Debashis ^a  

^a SCB Medical College   (India)

^b Trident Academy of Creative Technology   (India)

Author keywords

Cytokines; Day 0 10; IL 12; IL 4; Pf malaria; TNF alpha

Indexed keywords

ADENOSINE TRIPHOSPHATE; INTERLEUKIN 12; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE RELEASE; DISEASE COURSE; ENERGY METABOLISM; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOMODULATION; MALARIA FALCIPARUM; PATHOGENESIS; PROGNOSIS; PROTEIN BLOOD LEVEL;

PLASMODIUM FALCIPARUM;

EID: 84904760567     PISSN: 09701915     EISSN: 09740422     Source Type: Journal    
DOI: 10.1007/s12291-013-0359-3     Document Type: Article

References (30)

1. Schofield L, Grau GE. Immunological processes in malaria pathogenesis. Nat Rev Immunol. 2005;5:722-35. (Pubitemid 43086173)
2. Berendt AR, Turner GDH, Newbold CI. Cerebral malaria: the sequestration hypothesis. Parasitol Today. 1994;10:412-4. (Pubitemid 24306851)
3. Clark IA, Rockett KA. The cytokine theory of human cerebral malaria. Parasitol Today. 1994;10:410-2. (Pubitemid 24306850)
4. Schofield and Hackett. Signal transduction in host cells by a glycosylphosphatidylinositol toxin of malaria parasites. J Exp Med. 1993;177:145-53.
5. Pichyangkul S, Saengkrai P, Webster HK. Plasmodium falciparum pigment induces monocytes to release high levels of tumor necrosis factor-alpha and interleukin-1 beta. Am J Trop Med Hyg. 1994;51:430-5. (Pubitemid 24324758)
6. Ghigo D, Todde R, Ginsburg H, et al. Erythrocyte stages of Plasmodium falciparum exhibit a high nitric oxide synthase (NOS) activity and release an NOS inducing soluble factor. J Exp Med. 1995;182:677-88.
7. Luty FJA, Perkins PJ, Lell B, Ott SR, Lehman GL, Luckner D, Greve B, Matousek P, Herbich K, Schmid D, Weinberg BJ, Kremsner GP. Low interleukin 12 activity in severe Plasmodium falciparum malaria. Infect Immun. 2000;68:3909-15. (Pubitemid 30434540)
8. Pasvol G. Cell-cell interaction in the pathogenesis of severe falciparum malaria. Clin Med. 2001;1:495-500.
9. Clark AI, Budd CA, Alleva ML, Cowden BW. Human malarial disease: a consequence of inflammatory cytokine release. Malar J. 2006;5:85-117.
10. Winkler S, Willheim M, Baier K, Schmid D, Aichelburg A, Graninger W, Kremsner PG. Reciprocal regulation of Th1 and Th2-cytokine-producing T cells during clearance of parasitemia in Plasmodium falciparum malaria. Infect Immun. 1998;66:6040-4. (Pubitemid 28531874)
11. Day NP, Hien TT, Schollaardt T, Loc PP, Chuong LV, Chau TT, Mai NT, Phu NH, Sinh DX, Whithe NJ, Ho M. The prognostic and pathophysiology role of pro- and anti-inflammatory cytokines in severe malaria. J Infect Dis. 1999;180:1288-97. (Pubitemid 30070216)
12. Plebanski M, Hill AVS. The immunology of malaria. Curr Opin Immunol. 2000;12:437-41.
13. Gogos CA, Drosou E, Bassaris HP, Skoutelis A. Pro-versus antiinflammatory cytokine profile in patients with severe sepsis: a marker of prognosis and future therapeutic options. J Infect Dis. 2000;181:176-80. (Pubitemid 30049046)
14. McGuire W, Hill A, Allsopp CE, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature. 1994;371:508-10.
15. Kwiatkowski D, Cannon JG, Manogue KR, Cerami A, Dinarello CA, Greenwood BM. Tumour necrosis factor production in falciparum malaria and its association with schizont rupture. Clin Exp Immunol. 1989;77:361-6. (Pubitemid 19234383)
16. Kwiatkowski D, Molyneux ME, Stephens S, et al. Anti-TNF therapy inhibits fever in cerebral malaria. Q J Med. 1993;86:91-8. (Pubitemid 23125001)
17. Tripp CS, Wolf SF, Unanue ER. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA. 1993;90:3725-9. (Pubitemid 23111440)
18. Crutcher JM, Stevenson MM, Sedegah M, Hoffman SL. Interleukin 12 and malaria. Res Immunol. 1995;146:552-9.
19. Essner R, Rhoades K, McBride WH, Morton DL, Economou JS. IL-4 down-regulates interleukin-1 and TNF gene expression in human monocytes. J Immunol. 1989;142:3857-61. (Pubitemid 19164414)
20. Paul WE. Interleukin-4: a prototypic immunoregulatory lymphokine. Blood. 1991;77:1859-70.
21. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol. 1999;17:701-38. (Pubitemid 29241138)
22. Vitetta ES, Ohara J, Myers C, Layton J, Krammer PH, Paul WE. Serological, biochemical, and functional identity of B-cell stimulatory factor-1 and B cell differentiation factor for IgGl. J Exp Med. 1985;162:1726-31. (Pubitemid 16195372)
23. Zubiaga AM, Muñoz E, Huber BT. IL-4 and IL-2 selectively rescue Th cell subsets from glucocorticoid-induced apoptosis. J Immunol. 1992;149:107-12.
24. Illera VA, Perandones CE, Stunz LL, Mower DA, Ashman RF. Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4. J Immunol. 1993;151:2965-73. (Pubitemid 23282609)
25. Seder RA, Paul WE, Davis MM, De St Groth BF. The presence of interleukin-4 during in vitro priming determines the lymphokine producing potential of CD4+ T cells from T cell receptor transgenic mice. J Exp Med. 1992;179:1091-8.
26. Mosmann TR, Coffman RL. Th1 and Th2 cells: different pattern of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145-73. (Pubitemid 19138011)
27. Zamorano J, Kelly AE, Austrian J, Wang HY, Keegan AD. Costimulation of resting B lymphocytes alters the IL-4-activated IRS2 signaling pathway in a STAT6 independent manner: implications for cell survival and proliferation. Cell Res. 2001;11:44-54. (Pubitemid 33677181)
28. Zamorano J, Wang HY, Wang LM, Pierce JH, Keegan AD. IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway. J Immunol. 1996;157:4926-34. (Pubitemid 126449569)
29. Yanagida M, Fukamachi H, Ohgami K, Kuwaki T, Ishii H, Uzumaki H, et al. Effects of T-helper 2-type cytokines, interleukin-3 (IL-3), IL-4, IL-5, and IL-6 on the survival of cultured human mast cells. Blood. 1995;86:3705-14.
30. Lutz MB, Schnare M, Menges M, Rossner S, Rollinghoff M, Schuler G, et al. Differential functions of IL-4 receptor types I and II for dendritic cell maturation and IL-12 production and their dependency on GM-CSF. J Immunol. 2002;169:3574-80.